Cohen Capital Management, Inc. - AbbVie Inc. ownership

AbbVie Inc.'s ticker is and the CUSIP is 002874Y10. A total of 2 filers reported holding AbbVie Inc. in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Cohen Capital Management, Inc. ownership history of AbbVie Inc.
ValueSharesWeighting
Q4 2021$1,359,000
+25.5%
10,0380.0%0.22%
+18.1%
Q3 2021$1,083,000
-4.2%
10,0380.0%0.19%
-2.6%
Q2 2021$1,131,000
+4.1%
10,0380.0%0.19%
-3.0%
Q1 2021$1,086,000
+0.8%
10,038
-0.2%
0.20%
-7.4%
Q4 2020$1,077,000
+22.5%
10,055
+0.2%
0.22%
+8.0%
Q3 2020$879,000
-10.9%
10,0380.0%0.20%
-17.8%
Q2 2020$986,000
+28.9%
10,0380.0%0.24%
+7.6%
Q1 2020$765,000
-13.9%
10,0380.0%0.22%
+16.6%
Q4 2019$889,000
+17.0%
10,0380.0%0.19%
+10.3%
Q3 2019$760,000
+4.1%
10,0380.0%0.18%
+2.9%
Q2 2019$730,000
-9.8%
10,0380.0%0.17%
-12.8%
Q1 2019$809,000
-12.5%
10,0380.0%0.20%
-23.8%
Q4 2018$925,000
-2.5%
10,0380.0%0.26%
+19.6%
Q3 2018$949,000
+2.0%
10,0380.0%0.21%
-0.5%
Q2 2018$930,000
-9.3%
10,0380.0%0.22%
-10.8%
Q1 2018$1,025,000
+5.6%
10,0380.0%0.24%
+6.6%
Q4 2017$971,000
+8.9%
10,0380.0%0.23%
+4.6%
Q3 2017$892,000
+22.5%
10,0380.0%0.22%
+19.3%
Q2 2017$728,000
+11.3%
10,0380.0%0.18%
+9.7%
Q1 2017$654,000
+4.0%
10,0380.0%0.16%
-3.5%
Q4 2016$629,000
-0.6%
10,0380.0%0.17%
-3.4%
Q3 2016$633,000
+1.9%
10,0380.0%0.18%
-2.2%
Q2 2016$621,000
+4.4%
10,0380.0%0.18%
+0.6%
Q1 2016$595,0000.0%10,0380.0%0.18%0.0%
Q4 2015$595,000
+9.0%
10,0380.0%0.18%
+10.4%
Q3 2015$546,000
-19.0%
10,0380.0%0.16%
-6.3%
Q2 2015$674,000
+14.6%
10,0380.0%0.17%
+16.0%
Q1 2015$588,000
-10.5%
10,0380.0%0.15%
-11.8%
Q4 2014$657,000
+13.3%
10,0380.0%0.17%
+9.7%
Q3 2014$580,000
+2.3%
10,0380.0%0.16%
+6.2%
Q2 2014$567,000
+9.9%
10,0380.0%0.15%
+5.0%
Q1 2014$516,000
-2.6%
10,0380.0%0.14%
-6.7%
Q4 2013$530,000
+18.0%
10,0380.0%0.15%
+8.0%
Q3 2013$449,000
+8.2%
10,0380.0%0.14%
+3.8%
Q2 2013$415,00010,0380.13%
Other shareholders
AbbVie Inc. shareholders Q4 2016
NameSharesValueWeighting ↓
GLYNN CAPITAL MANAGEMENT LLC 25,000$1,033,0000.42%
Cohen Capital Management, Inc. 10,038$415,0000.13%
View complete list of AbbVie Inc. shareholders